Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Short-term Effects of an SGLT2 Inhibitor on Divalent Ions in Autosomal Dominant Polycystic Kidney Disease

NCT06435858 is registered in ClinicalTrials.gov with Cantonal Hospital Graubuenden as lead sponsor.

NCT NCT06435858
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06435858 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Short-term Effects of an SGLT2 Inhibitor on Divalent Ions in Autosomal Dominant Polycystic Kidney Disease
Lead sponsor
Cantonal Hospital Graubuenden
Phase
Phase 2
Overall status
Completed
Start date
September 1, 2024
Completion date
December 1, 2025
Enrollment
16 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

autosomal dominant polycystic kidney disease